Advertisement

Acta Endoscopica

, Volume 21, Issue 5, pp 671–680 | Cite as

Les œsophagites « primitives » ďorigine médicamenteuse a propos de 978 observations (1970-1990)

  • J. -B. Ollyo
  • Ch. Fontolliet
  • J. Wellinger
  • E. Brossard
  • Ph. Monnier
Article

Résumé

La prévalence et ľincidence des œsophagites directement induites par des médicaments sont probablement sous-estimées. Les principaux agents responsables sont les antibiotiques, le bromure ďémépronium et les anti-inflammatoires. Le principal facteur favorisant est ľingestion du médicament sans eau et/ou de sa prise en position allongée. Ľendoscopie est indispensable pour le diagnostic; elle révèle habituellement des érosions localisées au niveau des deux-tiers supérieurs de ľœsophage. Ľévolution des lésions œsophagiennes est généralement favorable aprés ľarrêt du médicament incriminé. Des complications graves (sténose, perforation, hémorragie), parfois mortelles (6 cas), ne sont pas exceptionnelles.

Mots-clés

endoscopie médicaments œsophage œsophagite 

« Primitive » drug-induced oesophagitis. about 978 observations (1970-1990)

Summary

The prevalence and incidence of oesophagitis directly caused by drug is probably underestimated. The principal causal agents are the antibiotics, emepronium bromide and the anti-inflammatory drugs. The principal propitious factor is the ingestion of the drug without water and/or in a reclining position. Endoscopy is essential for the diagnosis; it usually reveals localized erosions in the upper two thirds of the oesophagus. The evolution of these oesophageal erosions is generally favourable, as soon as the incriminated medication is withdrawn. However, serious complications (stenosis, perforation, haemorrhage), and sometimes even death (6 cases), are not exceptional.

Key-words

drugs endoscopy oesophagitis oesophagus 

Las esofagitis « primitivas » de origen medicamentoso. a proposito de 978 observaciones (1970-1990)

Resumen

La prevalencia y la incidencia de esofagitis directamente inducida por medicamentos estan probablemente sub-estimadas. Los principales agentes responsables son los antibióticos, el bromuro de emepronio y los anti-inflamatorios. El principal factor favorecedor es la ingestión del medicamento sin agua y/o su toma en posición horizontal. La endoscopia es indispensable para el diagnóstico; ella revela habitualmente las erosiones localizadas a nivel de los dos tercios superiores del esófago. La evolución de la lesiones esofágicas es generalmente favorable después de suspender el medicamento incriminado. Complicaciones graves (estenosis, perforación, hemorragia), algunas veces mortales (6 casos), no son excepcionales.

Palabras claves

endoscopía esofagitis esófago medicamentos 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    ADLER J.B. — Mexiletine-induced pill esophagitis.Dig. Dis. Sci., 1990, 85, 629–630.Google Scholar
  2. 2.
    ALGAYRES J.P., VALMARY J., CHABIERSKI M., DALY J.P., ROUGIER Y. — Ulcère œsophagien après prise de minocycline.Presse Med., 1989, 18, 541.PubMedGoogle Scholar
  3. 3.
    AL MAHDY H., BOSWELL G.V. — Captopril-induced œsophagitis.Eur. J. Clin. Pharmacol., 1988, 34, 95.PubMedCrossRefGoogle Scholar
  4. 4.
    ANONYMOUS. — Esofagusskador av lákemedel i Sverige 1965-1989.Läkartidningen, 1990, 87, 2368–2369.Google Scholar
  5. 5.
    ASHOUR M., SALAMA F.D., MORRI S.A., SKINNER J. — Acute dysphagia induced by bendrofluazide-K.Practitioner, 1984, 228, 524–525.PubMedGoogle Scholar
  6. 6.
    BAILEY R.T., BONAVINA L., NWAKAMA P.E., DE MEESTER T.R., CHENG S.C. — Influence of dissolution rate and pH of oral medications on drug-induced esophageal injury.DICP, 1990, 24, 571–574.PubMedGoogle Scholar
  7. 7.
    BECOUARN Y., LAMOULIATTE H., QUINTON A. — Lésions aiguës de ľcesophage ďorigine médicamenteuse.Gastroenterol. Clin. Biol., 1983, 7, 868–876.PubMedGoogle Scholar
  8. 8.
    BONAVINA L., DE MEESTER T.R., MCCHESNEY L., SCHWIZER W., ALBERTUCCI M., BAILEY R.T. — Drug-induced esophageal strictures.Ann. Surg., 1987, 206, 173–183.PubMedCrossRefGoogle Scholar
  9. 9.
    BOTT S., PRAKASH C., MCCALLUM R.W. — Medication-induced esophageal injury-survey of the literature.Am. J. Gastroenterol., 1987, 82, 758–763.PubMedGoogle Scholar
  10. 10.
    CARLBORG B., KUMLIEN A., OLSSON H. — Medikamentella esophagus strikturer.Lakartidningen, 1978, 75, 4609–4611.PubMedGoogle Scholar
  11. 11.
    CHEN P.C. — Antibiotic-induced esophageal ulcer.Chang Gung Med. J., 1987, 10, 129–132.Google Scholar
  12. 12.
    CUMMIN A.R.C., HANGARTNER J.R.W. — Oesophago-atrial fistula: a side effect of tetracycline?J.R. Soc. Med., 1990, 83, 745–746.PubMedGoogle Scholar
  13. 13.
    DE MEESTER T.R. — The limitations of 24-hour pH monitoring of the esophagus, in: De MEESTER T.R., SKINNER D.B. Esophageal disorders : pathophysiology and therapy. Raven Press New York, 1985, 109–117.Google Scholar
  14. 14.
    FENNERTY B., SAMPLINER R., GAREWAL H. — Esophageal ulceration associated with 13-cis-retinoic acid therapy in patients with Barrett’s esophagus.Gastrointest. Endosc., 1989, 35, 442–443.PubMedCrossRefGoogle Scholar
  15. 15.
    FIEDOREK S.C., CASTEEL H.B. — Pediatric medication-induced focal esophagitis.Clin. Pediatr., 1988, 27, 455–456.CrossRefGoogle Scholar
  16. 16.
    FISH A., ELIAKIM R., GOLDIN E. — Doxycyclineinduced esophageal ulcer.Harefuah., 1986, 11, 509–510.Google Scholar
  17. 17.
    FONTOLLIET Ch., WELLINGER J., OLLYO J.B., MONNIER P., SAVARY M. — Endoscopic and histological study of acute drug related esophagitis: 33 cases.Gastroenterology, 1989, 96, A 155.Google Scholar
  18. 18.
    HOWARD P.J., HEADING R.C. — The role of œsophageal transit in relation of drug delivery. in: HARDY J.G., DAVIS S.S., WILSON C.G. Drug delivery to the gastrointestinal tract. Halsted Press, New York, 1990, 27–36.Google Scholar
  19. 19.
    JAHRAUS T.C., KNIGHT W.A. Jr. — Esophageal « tattooing ».Gastrointest. Endosc., 1989, 35, 475.PubMedCrossRefGoogle Scholar
  20. 20.
    JUNCOSA L. — Ulcus péptico yatrogeno del esofago.Rev. Esp. Enf. Ap. Dig., 1970, 30, 457–458.Google Scholar
  21. 21.
    KALEVA M., KOLARSKI V., PETROVA-SHOPOVA K., NIKOLOV St., VASSILEVA E., PETROVA D. — Doxycycline esophagitis and esophageal ulcer.Vatr. Bol., 1988, 27, 63–67.Google Scholar
  22. 22.
    KATO S., KOBAYASHI M., SATO H., DAITO Y., KOMATSU K., HARADA Y. — Doxycycline-induced hemorrhagic esophagitis: a pediatric case.J. Pediatri. Gastroenterol. Nutr., 1988, 7, 762–765.CrossRefGoogle Scholar
  23. 23.
    KIKENDALL J.W., FRIEDMANN A.C., OYEWOLE M.A., FLEISCHER D., JOHNSON L.F. — Pill-induced esophageal injury. Case reports and review of the medical literature.Dig. Dis. Sci., 1983, 28, 174–182.PubMedCrossRefGoogle Scholar
  24. 24.
    KIKENDALL J.W., SCHMIDT M., GRAEBER G.M., BURTON N.A., FALL S.M., JOHNSON L.F. — Pillinduced esophageal ulceration and stricture following cardiac surgery.Mil. Med., 1986, 151, 539–542.PubMedGoogle Scholar
  25. 25.
    KNAUER C.M., MCLAUGHLIN W.T., MARK J.B.D. — Esophago-esophageal fistula in a patient with achalasia.Gastroenterology, 1970, 58, 223–228.PubMedGoogle Scholar
  26. 26.
    LOFT E.D., STUBINGTON S., CLARK Ch., REES W.D.W. — Oesophageal ulcer caused by warfarin. Postgrad.Med. J., 1989, 65, 258–259.Google Scholar
  27. 27.
    MATTEO A., EYSSAUTIER B., RODOR F., GEROLAMI A. — Oesophagite ulcérée après prise de Selexid.Gastroenterol. Clin. Biol., 1988, 12, 670–671.PubMedGoogle Scholar
  28. 28.
    MCCORD G.S., CLOUSE R.E. — Pill-induced esophageal strictures: clinical features and risk factors for development.Am. J. Med., 1990, 88, 512–518.PubMedCrossRefGoogle Scholar
  29. 29.
    NETTER P., PAILLE F., TRECHOT P., BANNWARTH B., ROYER R.J. — Les complications œsophagiennes ďorigine médicamenteuse.Thérapie, 1988, 43, 475–479.PubMedGoogle Scholar
  30. 30.
    OLLYO J.B., FONTOLLIET Ch., MONNIER P., WELLINGER J., RESTELLINI A., GONVERS J.J., SAVARY M. — LĽœsophagite médicamenteuse et ses complications. Etude rétrospective de 30 observations et revue de 650 cas publiés (1970-1987).Schweiz. Rundschau Med. (Praxis)., 1990, 79, 394–397.Google Scholar
  31. 31.
    PEMBERTON J. — Oesophageal obstruction and ulceration caused by oral potassium therapy.Br. Heart. J., 1970, 32, 267–268.PubMedCrossRefGoogle Scholar
  32. 32.
    PERREARD M., KLOTZ F. — Oesophagite ulcérée après prise de spiramycine.Ann. Gastroenterol. Hépatol., 1989, 25, 313–314.Google Scholar
  33. 33.
    PERRY P.A., DEAN B.S., KRENZELOK E.P. — Druginduced esophageal injury.Clin. Toxicol., 1989, 27, 281–286.CrossRefGoogle Scholar
  34. 34.
    PINOS T., FIGUERAS C., MAS R. — Doxycyclineinduced esophagitis: treatment with liquid sucralfate.Am. J. Gastroenterol., 1990, 85, 902–903.PubMedGoogle Scholar
  35. 35.
    RAMBAUD S., ELKHARRAT D., GAJDOS P. — Ulcération œsophagienne après prise Ďampicilline.Ann. Med. Int., 1990, 141, 275.Google Scholar
  36. 36.
    RAVICH W.J., KASHIMA H., MARTIN W., DONNER W. — Drug-induced esophagitis simulating esophageal carcinoma.Dysphagia, 1986, 1, 13–18.CrossRefGoogle Scholar
  37. 37.
    RUNYON B.A. — Pill-induced esophageal variceal hemorrhage in a patient treated with sclerotherapy.J. Clin. Gastroenterol., 1986, 8, 696.PubMedCrossRefGoogle Scholar
  38. 38.
    SCHREIBER J.B., COVINGTON J.A. — Aspirin-induced esophageal hemorrhage.JAMA, 1988, 259, 1647–1648.PubMedCrossRefGoogle Scholar
  39. 39.
    SEIBERT D., AL-KAWAS F. — Trimethoprim-sulfamethoxazole, hiccups, and esophageal ulcers.Ann. Intern. Med., 1986, 105, 976.PubMedGoogle Scholar
  40. 40.
    SHEMESH E., BATT L. — Esophageal ulceration caused by tetracycline.Harefuah., 1980, 99, 373–374.PubMedGoogle Scholar
  41. 41.
    STRICKER B.H.Ch., DE SMET P.A.G.M. — Slokdarmbeschadiging door geneesmiddelen.Ned. Tijdschr. Geneeskd., 1987, 131, 868–873.PubMedGoogle Scholar
  42. 42.
    SUISSA A., PARASON M., LACHTER J., EIDELMANN S. — Penicillin VK-induced esophageal ulcerations.Am. J. Gastroenterol., 1987, 82, 482–483.PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • J. -B. Ollyo
    • 1
    • 2
    • 3
  • Ch. Fontolliet
    • 1
  • J. Wellinger
    • 2
  • E. Brossard
    • 1
    • 2
    • 3
  • Ph. Monnier
    • 1
    • 2
    • 3
  1. 1.Institut Universitaire de PathologieLausanneSuisse
  2. 2.Dépt. de Chirurgie, Centre Hospitalier Universitaire VaudoisLausanneSuisse
  3. 3.Service ORL, CHUVLausanneSuisse

Personalised recommendations